Bank Of America Corp Angion Biomedica Corp. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.48 - $1.02 $5,157 - $10,959	10,745 Added 52.7%	31,135 $18,000
Q4 2022 Feb 10, 2023	SELL	$0.8 - $1.0 $7,913 - $9,892	-9,892 Reduced 32.67%	20,390 $16,000
Q3 2022 Nov 14, 2022	SELL	$0.94 - $1.23 $13,368 - $17,493	-14,222 Reduced 31.96%	30,282 $28,000
Q2 2022 Aug 12, 2022	SELL	$1.1 - $2.23 $20,825 - $42,218	-18,932 Reduced 29.84%	44,504 $50,000
Q1 2022 May 16, 2022	SELL	$1.72 - $2.96 $6,484 - $11,159	-3,770 Reduced 5.61%	63,436 $134,000
Q4 2021 Feb 08, 2022	BUY	$2.35 - $9.95 $88,945 - $376,597	37,849 Added 128.93%	67,206 $195,000
Q3 2021 Nov 15, 2021	BUY	$9.31 - $13.25 $188,462 - $268,219	20,243 Added 222.11%	29,357 $287,000
Q2 2021 Sep 13, 2021	BUY	$13.02 - $17.83 $118,664 - $162,502	9,114 New	9,114 $119,000

Ticker ANGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,113,300
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.